These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Potassium homeostasis in chronic experimental diabetes mellitus in rats. Hayashi M, Senba S, Saito I, Kitajima W, Saruta T. Acta Endocrinol (Copenh); 1984 Feb; 105(2):239-44. PubMed ID: 6364673 [Abstract] [Full Text] [Related]
3. Renal excretion of prostaglandin E2 and plasma renin activity in type I diabetes mellitus: relationship to normoglycemia achieved with artificial pancreas. Esmatjes E, Levy I, Gaya J, Rivera F. Diabetes Care; 1987 Feb; 10(4):428-31. PubMed ID: 3304894 [Abstract] [Full Text] [Related]
4. The mechanism of the control of renin release by beta-adrenergic receptors. Suzuki S, Hashiba K. Jpn Heart J; 1986 Nov; 27(6):871-80. PubMed ID: 3033346 [Abstract] [Full Text] [Related]
10. Glandular kallikrein, renin and angiotensin converting enzyme of diabetic and hypertensive rats. Handa H, Sakurama S, Nakagawa S, Yasukouchi T, Sakamoto W, Izumi H. Adv Exp Med Biol; 1989 Feb; 247B():443-8. PubMed ID: 2558514 [Abstract] [Full Text] [Related]
11. Renal prostaglandin E2 and the renin-angiotensin system in hypertensive disorders in man. Kuylenstierna J, Karlberg BE, Morales O. Prostaglandins Leukot Med; 1985 Apr; 18(1):19-30. PubMed ID: 3889934 [Abstract] [Full Text] [Related]
12. Papillary collecting tubule synthesis of prostaglandin E2 in Dahl rats. Reid GM, Appel RG, Dunn MJ. Hypertension; 1988 Feb; 11(2):179-84. PubMed ID: 3422633 [Abstract] [Full Text] [Related]
14. Quinacrine antagonizes the effects of Na,K-ATPase inhibitors on renal prostaglandin E2 release but not their effects on renin secretion. Churchill PC, Churchill MC, McDonald FD. Life Sci; 1985 Jan 21; 36(3):277-82. PubMed ID: 2981387 [Abstract] [Full Text] [Related]
15. Effect of enalapril (MK-421), an orally active angiotensin I converting enzyme inhibitor, on blood pressure, active and inactive plasma renin, urinary prostaglandin E2, and kallikrein excretion in conscious rats. Schiffrin EL, Gutkowska J, Thibault G, Genest J. Can J Physiol Pharmacol; 1984 Jan 21; 62(1):116-23. PubMed ID: 6143602 [Abstract] [Full Text] [Related]
17. Effect of insulin pump therapy on blood pressure and the renin-angiotensin system of diabetic rats. Hartmann JF, Chen SL, Szemplinski M, Slater EE. Horm Metab Res; 1990 Mar 21; 22(3):141-4. PubMed ID: 2188897 [Abstract] [Full Text] [Related]
18. Different patterns of renal prostaglandins I2 and E2 in patients with essential hypertension with low to normal or high renin activity. Tsuji T, Yasu T, Katayama Y, Imanishi M. J Hypertens; 2000 Aug 21; 18(8):1091-6. PubMed ID: 10954001 [Abstract] [Full Text] [Related]
19. Lack of relationship between prostaglandin E2 release and renin secretion in rat renal cortical slices. Churchill PC, Savoy-Moore RT, Churchill MC. J Pharmacol Exp Ther; 1983 Jul 21; 226(1):46-51. PubMed ID: 6345755 [No Abstract] [Full Text] [Related]
20. Changes in blood pressure, urinary kallikrein, and urinary prostaglandin E2 in rats with streptozotocin-induced diabetes. Hayashi M, Senba S, Saito I, Kitajima W, Saruta T. Naunyn Schmiedebergs Arch Pharmacol; 1983 May 21; 322(4):290-4. PubMed ID: 6346111 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]